Glenmede Trust’s GoodRx Holdings GDRX Stock Holding History

Glenmede Trust’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-403	Closed	-$22K	–	1612
2020 Q3	$22K	Buy	+403	New	+$21.3K	﹤0.01%	1583

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Glenmede Trust's GDRX Position: Q4 2020 in Review

Glenmede Trust sold out of GoodRx Holdings (GDRX) in Q4 2020, closing a stake of 403 shares — an estimated $22K sold.

Glenmede Trust first reported a position in GDRX in Q3 2020 and held it in 1 quarter. The position peaked at $22K in Q3 2020. 192 funds tracked by Wall St. Rank hold GDRX as of Q4 2020.

Glenmede Trust reported no remaining GoodRx Holdings position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 403 GoodRx Holdings shares in Q4 2020, an estimated $22K.
Glenmede Trust first reported a position in GoodRx Holdings in Q3 2020 and held it in 1 quarter.
Glenmede Trust's GoodRx Holdings position peaked at $22K in Q3 2020.
192 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.